Colt Ventures proving a broad range of investment activities and has the flexibility to invest in a wide variety of asset classes.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | — |
May 20, 2021
Rumble
|
Series Unknown | — | Content Creators | — |
Mar 26, 2020
ReCode Therapeutics
|
Series A | $80M | Biopharma | Yes |